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H NMR spectrum of compound 1 (CD3OD, 500 MHz). 
 
Figure 3S.  
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C NMR spectrum of compound 13 (CD3OD, 125 MHz). 
 
Figure 16S. HSQC spectrum of compound 13 (CD3OD). 
 
Figure 17S. Heptanoid and glucosidic part of the HMBC spectrum of compound 13     
(CD3OD). 
 
Figure 18S. Aromatic part of the HMBC spectrum of compound 13 (CD3OD). 
 
Figure 19S. Aromatic part of the 
1
H NMR spectrum of isomer mixture of compound 14 




H NMR spectrum of the pure compound 14 (CD3OD, 500 MHz). 
 
Figure 21S. Aromatic part of the 
1
H NMR spectrum of compound 14 (CD3OD, 500 MHz). 
 
Figure 22S. Heptanoid and glucosidic part of the 
1
H NMR spectrum of compound 14 
(CD3OD, 500 MHz). 
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 Figure 23S. 
13
C NMR spectrum of compound 14 (CD3OD, 125 MHz). 
 
Figure 24S. HSQC spectrum of compound 14 (CD3OD). 
 
Figure 25S. Heptanoid and glucosidic part of the HMBC spectrum of compound 14 
(CD3OD). 
 
Figure 26S. Aromatic part of the HMBC spectrum of compound 14 (CD3OD). 
 
Figure 27S. Correlations from HMBC spectrum of 10, showing that C-1' has lower chemical 
shift than C-1''. 
 
Figure 28S. Mass spectrum and empirical formula confirmation report of compound 13. 
 
Figure 29S. Mass spectrum and empirical formula confirmation report of compound 14. 
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 1S. Cytokinesis-block micronucleus assay  
The whole blood lymphocytes were treated with two concentrations of 
diarylheptanoids (1.0 and 2.0 µg/mL). One cell culture without investigated compounds added 
served as the control. One cell culture containing Amifostine WR-2721 (1 μg/mL) (Marligen-
Biosciences) was used as a positive control, and mitomycin C (MMC) (0.1 μg/mL, in 
phosphate buffer) as a negative control. They were added to the cultures 25 h after 
phytohaemagglutinin (PHA; Invitrogen Gibco-BRL, 2.4 μg/mL) stimulation and left until 
harvest. All cultures were incubated in a thermostat at 37ºC. Treatment with diarylheptanoids 
lasted for 19 h, whereafter all cultures were rinsed with pure medium, transferred into 5 mL 
fresh RPMI 1640 medium (RPMI 1640 Medium + GlutaMAX + 25 mM HEPES; Invitrogen- 
Gibco-BRL) and incubated for additional 72 h.  
For MN preparation, the cytokinesis-block method of Fenech and Morley (1993) was 
used with some modifications, as described in the work of Stanković et al. (2008). At least 
1000 binucleated (BN) cells per sample were scored, registering MN according to the criteria 
of Countryman and Heddle (1976), and Fenech and Morley (1993). Cytochalasin B 
(Invitrogen- Gibco-BRL), at a final concentration of 6 μg/mL, was added to the samples after 
44 h of culture, and the lymphocyte cultures were incubated for a further 24 h. After 72 h of 
culture, the cells were washed with 0.9% NaCl (Merck, Sharp, and Dohme GMBH), collected 
by centrifugation, and treated with hypotonic solution at 37°C. The hypotonic solution 
consisted of 0.56% KCl + 0.9% NaCl (mixed in equal volumes). The cell suspension was 
prefixed in methanol/acetic acid (3:1), washed three times with fixative and dropped onto a 
clean slide (Fenech and Morley, 1993). The slides were air-dried and stained with alkaline 
Giemsa (Sigma-Aldrich) (2%).  





































































































































































H NMR spectrum of compound 1 (CD3OD, 500 MHz). 





































































































































































H NMR spectrum of compound 2 (CD3OD, 500 MHz). 




















































































































































































































H NMR spectrum of compound 3 (CD3OD, 500 MHz). 














































































































H NMR spectrum of compound 4 (CD3OD, 500 MHz). 






























































































































































H NMR spectrum of compound 5 (CD3OD, 500 MHz). 


































































































































H NMR spectrum of compound 6 (CD3OD, 500 MHz). 





























































































































































































H NMR spectrum of compound 7 (CD3OD, 500 MHz). 














































































































































































































H NMR spectrum of compound 8 (CD3OD, 500 MHz). 













































































































































































H NMR spectrum of compound 9 (CD3OD, 500 MHz). 




















































































































































































































H NMR spectrum of compound 10 (CD3OD, 500 MHz). 







































































































































































































H NMR spectrum of compound 11 (CD3OD, 500 MHz). 







































































































































































































































































H NMR spectrum of compound 12 (CD3OD, 500 MHz). 






















































































































































































































H NMR spectrum of compound 13 (CD3OD, 500 MHz). 






























































































































C NMR spectrum of compound 13 (CD3OD, 125 MHz). 
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Figure 16S. HSQC spectrum of compound 13 (CD3OD). 








































Figure 17S. Heptanoid and glucosidic part of the HMBC spectrum of compound 13 (CD3OD). 


































Figure 18S. Aromatic part of the HMBC spectrum of compound 13 (CD3OD). 










Figure 19S. Aromatic part of the 
1
H NMR spectrum of isomer mixture of compound 14 (CD3OD, 500 MHz). 
 












































































H NMR spectrum of the pure compound 14 (CD3OD, 500 MHz). 















































































Figure 21S. Aromatic part of the 
1
H NMR spectrum of compound 14 (CD3OD, 500 MHz). 
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Figure 22S. Heptanoid and glucosidic part of the 
1





















































































































































































































































































































































































































































C NMR spectrum of compound 14 (CD3OD, 125 MHz). 
































Figure 24S. HSQC spectrum of compound 14 (CD3OD). 





































Figure 25S. Heptanoid and glucosidic part of the HMBC spectrum of compound 14 (CD3OD). 




































Figure 26S. Aromatic part of the HMBC spectrum of compound 14 (CD3OD). 
 
 

















































Figure 27S. Correlations from HMBC spectrum of 10, showing that C-1' has lower chemical shift than C-1''. 
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Figure 28S. Mass spectrum and empirical formula confirmation report of compound 13.
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Figure 29S. Mass spectrum and empirical formula confirmation report of compound 14.
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Figure 30S. CD spectra of compounds 7, 13, and 14. 
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